Poliomyelitis leading to large-scale trials in the then Belgian Congo and the vaccination of seven million children in Poland against serotypes PV1 and PV3 between 1958 and 1960. The second inactivated polio virus vaccine was developed in 1952 by Jonas Salk at the University of Pittsburgh, and announced to the world on 12 April 1955. The Salk vaccine, or inactivated poliovirus vaccine, is based on poliovirus grown in a type of monkey kidney tissue culture (vero cell line), which is chemically inactivated with formalin. After two doses of inactivated poliovirus vaccine (given by injection), 90 percent or more of individuals develop
Salk Hall 1920s. Also contained in Salk Hall is the Elmer H. Grimm Sr. Pharmacy Museum, which opened in the fall of 1996. Located on the fourth floor, the museum holds pharmacy memorabilia such as drug products, equipment, and sundry products dating back to the early 20th century. Among the museum's possessions are two hand-carved finials, which were often found over the door or partitions that separated the main part of the pharmacy from the back room where pharmacists did most of their work, an old-fashioned powder mill, and a konseal machine. Salk Hall Jonas Salk Hall at the University of Pittsburgh